0000000000133061

AUTHOR

M.p. Manns

showing 7 related works from this author

IgG Subclass Distribution of Autoantibodies to Glomerular Basement Membrane in Goodpasture’s Syndrome Compared to Other Autoantibodies

1988

The IgG subclass distribution of autoantibodies to glomerular basement membrane (anti-GBM antibodies) was investigated and compared to the distribution of liver-kidney microsomal (LKM) autoantibodies in chronic active hepatitis, to antimitochondrial autoantibodies (AMA) in primary biliary cirrhosis, and to the subclass distribution of total serum IgG within a healthy population. Solid phase assays for the demonstration of these autoantibodies were performed with four mouse monoclonal antibodies specific for each human subclass to provide quantitative data for the autoantibodies. In addition, the subclass distribution of total IgG in these sera was analyzed. IgG1 accounted for 75% of the tot…

Anti-Glomerular Basement Membrane DiseaseRenal glomerulusmedicine.drug_classKidney GlomerulusPopulationMitochondria LiverMonoclonal antibodyBasement MembraneSubclassmedicineHumansGoodpasture syndromeeducationAutoantibodiesHepatitis Chroniceducation.field_of_studybiologyLiver Cirrhosis Biliarybusiness.industryGlomerular basement membraneAutoantibodymedicine.diseasemedicine.anatomical_structureImmunoglobulin GImmunologyMicrosomes Liverbiology.proteinAntibodybusinessNephron
researchProduct

Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing…

2016

Background Ulcerative colitis (UC), a complex polygenic disorder, is one of the main subphenotypes of inflammatory bowel disease. A comprehensive dissection of the genetic etiology of UC needs to assess the contribution of rare genetic variants including copy number variations (CNVs) to disease risk. In this study, we performed a multi-step genome-wide case-control analysis to interrogate the presence of disease-relevant rare copy number variants. Methods One thousand one hundred twenty-one German UC patients and 1770 healthy controls were initially screened for rare deletions and duplications employing SNP-array data. Quantitative PCR and high density custom array-CGH were used for validat…

GeneticsHepatologyIn silicoBiologymedicine.diseaseGenomeInflammatory bowel diseasePrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisGene duplicationGenotypemedicine030211 gastroenterology & hepatologyCopy-number variationGeneJournal of Hepatology
researchProduct

Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis

1988

Although the presence of anti-mitochondrial antibodies is the main characteristic of primary biliary cirrhosis (PBC), other autoantibodies have been described in this disease. This study employs immunoblot methods to test whether the sera of PBC patients also contain antibodies directed against nicotinic acetylcholine receptors (AChR). We show that the majority of patients' sera indeed react with AChR just as sera of myasthenic patients do. In contrast, however, these anti-AChR antibodies do not lead to significant clinical symptoms of myasthenia. In all cases studied, PBC sera recognized a protein with the molecular weight of the alpha-chain of acetylcholine receptor (40 kDa). In addition,…

medicine.medical_specialtyHepatologyLiver Cirrhosis BiliaryAutoantibodyBiologymedicine.diseaseImmunohistochemistryPrimary biliary cirrhosisNicotinic agonistEndocrinologyAntigenInternal medicinemedicinebiology.proteinHumansImmunohistochemistryElectrophoresis Polyacrylamide GelReceptors CholinergicIsoelectric PointAntibodyReceptorImmunosorbent TechniquesAutoantibodiesAcetylcholine receptorJournal of Hepatology
researchProduct

Expression of Pre-S-Encoded Proteins in Sera of Individuals Chronically Infected with Hepatitis D Virus

1988

The sera of 16 individuals chronically infected with the hepatitis D virus were analyzed for hepatitis B virus (HBV) markers. The majority of these patients had a non-replicative form of viral type B hepatitis as indicated by negative tests for HBeAg and HBV-DNA. Pre-S-encoded proteins were detected in 13/16 sera. Sera that were negative for polymerized serum albumin did also not contain pre-S1-encoded proteins. The presence of pre-S-encoded proteins is probably predominantly associated with 22-nm HBsAg forms present in large amounts in sera of individuals with chronic type D hepatitis.

Hepatitis B virusHepatitis b e antigenHepatitis B Surface AntigensvirusesGastroenterologyBiologymedicine.disease_causeHepatitis b surface antigenmedicine.diseaseVirologyHepatitis DHepatitis DViral Envelope ProteinsViral typeChronic DiseaseDNA ViralImmunologymedicineHumansHepatitis B e AntigensViral diseaseHepatitis D virusProtein PrecursorsDna viralDigestion
researchProduct

Detection of hepatitis B virus markers in sera of asymptomatic hepatitis B surface antigen carriers with special emphasis to pre-S-encoded proteins.

1987

Sera of asymptomatic hepatitis B surface antigen (HBsAg) carriers were analyzed for the presence of pre-S-encoded proteins. Four individuals with biopsy-proven chronic hepatitis uniformly expressed pre-S1- and pre-S2-encoded proteins. Individuals who had histologically normal or largely normal livers were heterogeneous with respect to expression of pre-S-encoded proteins. This heterogeneous expression of pre-S-encoded proteins occurred most likely due to difference in serum HBsAg concentration. Alternatively differences in pre-S gene expression need to be considered. Clinically the study indicates that expression of pre-S domains in serum is unrelated to viremia or chronic liver disease.

MaleHBsAgHepatitis B virusViremiamedicine.disease_causeChronic liver diseaseAsymptomaticGene expressionmedicineHumansProspective StudiesHepatitis B virusHepatitis B Surface Antigensbiologybusiness.industryGastroenterologyHepatitis Bmedicine.diseaseVirologyImmunologyCarrier StateDNA Viralbiology.proteinFemalemedicine.symptomAntibodybusinessDigestion
researchProduct

Prophylaxis, diagnosis and therapy of Hepatitis C Virus (HCV) infection : The German guidelines on the management of HCV infection

2010

business.industryHepatitis C virusMedizinGastroenterologyDrug resistanceHepatitis CHepatitis Bmedicine.diseasemedicine.disease_causeHepatitis DVirologyTransplantation03 medical and health sciences0302 clinical medicinePharmacotherapymedicine030211 gastroenterology & hepatology030212 general & internal medicineViral hepatitisbusinessZeitschrift für Gastroenterologie
researchProduct

Aktuelle Therapie der primären sklerosierenden Cholangitis*

2008

medicine.medical_specialtybusiness.industryGeneral surgeryArt therapymedicineGeneral Medicinemedicine.diseasebusinessPrimary sclerosing cholangitisDMW - Deutsche Medizinische Wochenschrift
researchProduct